Patents for C12P 21 - Preparation of peptides or proteins (112,499)
08/2010
08/03/2010US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders
08/03/2010US7767205 Erythropoietin-producing hepatocellullar kinase (EPH) specific immunoglobulin for use in treatment and prevention of tumor, cancer and/or cell proliferative disorders
08/03/2010CA2468295C Glycoprotein remodeling using endoglycanases
08/03/2010CA2401342C Human antibodies against eotaxin and their use
08/03/2010CA2353603C Udp-n- acetyl glucosamine: galactose-.beta.1, 3-n- acetyl galactosamine- .alpha.-r/ n- acetyl glucosamine -.beta.1, 3-n- acetyl galactosamine- .alpha.-r (glcnac to galnac) .beta.1,6-n- acetyl glucosaminyl transferase, c2/4gnt
08/03/2010CA2345905C Plant-optimized polynucleotides encoding approximately 15 kda and approximately 45 kda pesticidal proteins
08/03/2010CA2263106C Humanized immunoglobulin reactive with .alpha.4.beta.7 integrin
08/03/2010CA2262423C Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
08/03/2010CA2224777C New immunoregulatory protein lst-1
08/03/2010CA2190365C Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene
08/03/2010CA2188813C Angiostatin protein, nucleic acids encoding the same and methods of detection
08/03/2010CA2178057C Epstein-barr virus peptides and antibodies against these peptides
08/03/2010CA2133873C Tnf inhibitors
07/2010
07/29/2010WO2010084947A1 Process for producing heterologous polypeptide
07/29/2010WO2010084851A1 Peptide capable of binding to immunoglobulin
07/29/2010WO2010016943A3 Nutrient monitoring and feedback control for increased bioproduct production
07/29/2010WO2006009890A9 Methods and compositions for producing insulin sensitization
07/29/2010US20100192260 Polypeptides having alpha-glucosidase activity and polynucleotides encoding same
07/29/2010US20100192256 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
07/29/2010US20100192252 Transcription Factor Gene Induced by Water Deficit Conditions and Abscisic Acid from Helianthus Annuus, Promoter and Transgenic Plants
07/29/2010US20100192239 Modulation of Mu Delta Opioid Receptor Expression
07/29/2010US20100192238 Elongases and methods for producing polyunsaturated fatty acids in transgenic organisms
07/29/2010US20100190964 Antibodies to human ErbB4
07/29/2010US20100190962 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof
07/29/2010US20100190707 Novel Bacillus Thuringiensis Gene with Lepidopteran Activity
07/29/2010US20100190680 Polypeptides having lipase activity and polynucleotides encoding same
07/29/2010US20100190211 IL-18 Receptors
07/29/2010US20100190210 Protein Purification
07/29/2010US20100190209 Optimized dna sequences encoding recombinant human bone morphogenetic protein-2 (rhbmp-2), preparation method and the uses thereof
07/29/2010US20100190208 Acid fungal proteases
07/29/2010US20100190207 Expression Augmenting DNA Fragments, Use Thereof, and Methods for Finding Thereof
07/29/2010US20100190196 D-serine dehydratase and use thereof
07/29/2010US20100189794 Nucleic acid hydrogel via rolling circle amplification
07/29/2010US20100189722 Anti cd37 antibodies
07/29/2010US20100189720 Novel card proteins involved in cell death regulation
07/29/2010US20100189719 using monoclonal antibody or an Fab fragment capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, age-induced macular degeneration
07/29/2010US20100189717 Plant Recombinant Human CTLA4IG and a Method for Producing the Same
07/29/2010US20100189715 Humanized monoclonal antibodies that protect against shiga toxin induced disease
07/29/2010US20100189714 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods
07/29/2010US20100189706 Polypeptide enzymes that can hydrolyze lignocellulose such as sugarcane bagasse, i.e., for biomass processing, industrial uses such as disinfectants, pharmaceuticals, waste treatment, making biofuels, feeds and foods; bioconversion of lignocellulosic residues into fermentable sugars; heat stability
07/29/2010US20100189686 Albumin Fusion Proteins
07/29/2010US20100189682 Biologically active proteins having increased In Vivo and/or In Vitro stability
07/29/2010DE10392697B4 Extrakt von Peptid-verknüpften Glucanen und Peptid-verknüpfte Clucane mit nachweisbarer oraler Resorbierbarkeit aus Coriolus Versicolor und deren Reinigungsverfahren und Verwendungen Extract of peptide-linked glucans and peptide-linked Clucane with detectable oral absorbability from Coriolus versicolor and their cleaning methods and uses
07/28/2010EP2211177A1 Methods using O6-alkylguanine-DNA alkyltransferases
07/28/2010EP2210943A1 Novel aldolase and production process of substituted alpha-keto acids
07/28/2010EP2210940A1 Method for high-level secretion and production of protein
07/28/2010EP2210939A1 Anti-bst2 antibody
07/28/2010EP2210904A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof
07/28/2010EP2209908A1 Recombinant factor viii having increased stability
07/28/2010EP2209903A1 Promoter detection and analysis
07/28/2010EP2209809A1 Human monoclonal antibodies directed to sialyl lewis c, sialyl tn and n-glycolylneuraminic acid epitopes and a method of analysis of stem cells comprising said epitopes
07/28/2010EP1587921B1 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function
07/28/2010EP1244797B1 Translentiviral vector system
07/28/2010EP1137789B1 A method for manufacturing glycoproteins having human-type glycosylation
07/28/2010CN1651457B Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
07/28/2010CN101787387A Acid-resistant no-bitterness soybean oligopeptide and production method and application thereof
07/28/2010CN101787369A DNA sequence of optimized rhBMP (recombinant human bone morphogenetic protein)-2, preparation and purpose of encoding protein thereof
07/28/2010CN101787079A High-purity horse anti-rabies virus antibody F(ab')2 fragment
07/28/2010CN101787078A Collagen polypeptide, preparation method and application thereof
07/28/2010CN101058822B Method of extracting rice bran polysaccharide and rice bran protein
07/27/2010USRE41461 Purification, composition and specificity of Heparinase I, II, and III from Flavobacterium heparinum
07/27/2010US7763718 Free of transmembrane domain; immunoglobulins; autoimmune diseases
07/27/2010US7763716 monoclonal antibodies capable of recognizing and neutralizing neuropeptide W (NPW) an endogenous ligands for human G protein coupled receptors, used in the medical diagnosis and preventing of infertility, kidney edema, peptic ulcer, gastric hyperacidity
07/27/2010US7763586 Melanoma antigens and their use in diagnostic and therapeutic methods
07/27/2010US7763466 Generating cells for cell replacement therapy
07/27/2010US7763449 Bioactive ribonucleases for treating tumors in humans
07/27/2010US7763446 nucleic acids encoding a chimeric protein comprising a cleavage domain and a composite nucleic acid-binding region, that comprises at least two component polypeptide portions which are individually capable of binding specific nucleotide sequences
07/27/2010US7763445 Dimeric fusion proteins and materials and methods for producing them
07/27/2010US7763443 Expression vector comprising nucleotide sequences coding green fluorescent protein for use as reporter molecule in gene expression analysis
07/27/2010US7763431 screening for modulators and can be used as flavor additives in compositions for human or animal consumption
07/27/2010US7763262 Attenuated yiaO mutants of Pasteurellaceae bacteria
07/27/2010US7763250 Antibodies directed against amyloid-beta peptide and nucleic acids encoding same
07/27/2010US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease
07/27/2010US7763248 Humanized collagen antibodies and related methods
07/27/2010US7763246 Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptor
07/27/2010US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient.
07/27/2010CA2477163C Soluble form of carbonic anhydrase ix (s-ca-ix), assays to detect s-ca ix, and ca ix's coexpression with her-2/neu/c-erbb-2, and ca ix-specific monoclonal antibodies to non-immunodominant epitopes
07/27/2010CA2368944C Paramyxovirus-derived rnp
07/27/2010CA2338989C Antibodies for detecting microorganisms
07/27/2010CA2323091C Nephrin gene and protein
07/27/2010CA2223300C Expression of lipoproteins
07/27/2010CA2195385C An artificial recombinant substrate (ragg 1) and native aggrecan to study the proteolytic activity of 'aggrecanase' in cell culture systems
07/22/2010WO2010083179A2 Isolated novel nucleic acid and protein molecules from soybeans and methods of using those molecules to generate transgenic plants with enhanced agronomic traits
07/22/2010WO2010083148A1 Use of dna gyrase inhibitors for in vitro polypeptide synthesis reactions
07/22/2010WO2010082619A1 High expression promoter and method for producing gene product using same
07/22/2010WO2010082572A1 Novel expression vector
07/22/2010WO2010081741A1 A method for increasing protein expression in cells
07/22/2010WO2010062401A3 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
07/22/2010WO2010056901A3 Method of expressing proteins with disulfide bridges with enhanced yields and activity
07/22/2010WO2010027370A9 Compositions and methods for the treatment of solid tumor cancers
07/22/2010WO2009155008A9 Methods and compositions for production of recombinant protein in hbx-expressing mammalian cells
07/22/2010US20100186123 Suppression of Resistance in Insects to Bacillus Thuringiensis Cry Toxins, Using Toxins that do not Require the Cadherin Receptor
07/22/2010US20100186120 Organic compounds
07/22/2010US20100186100 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
07/22/2010US20100186099 Production of Human Glycosylated Proteins in Silk Worm
07/22/2010US20100184961 Methods and compositions related to chromatin-associated proteins and other factors
07/22/2010US20100184959 Polypeptide Variants
07/22/2010US20100184949 Method for the mass expression of an antimicrobial peptide by using a translational coupling system
07/22/2010US20100184709 Malt1 specific cleavage in assay and screening method
07/22/2010US20100184671 Binding molecules for the treatment of myeloid cell malignancies